PHYSIOLOGICAL REVIEWS   Vol. 79 No. 1 January 1999, pp. S193-S214
Copyright ©1999 The American Physiological Society

Pathophysiology of Gene-Targeted Mouse Models for Cystic Fibrosis

BARBARA R. GRUBB AND RICHARD C. BOUCHER

Cystic Fibrosis/Pulmonary Research and Treatment Center, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Grubb, Barbara R., and Richard C. Boucher. Pathophysiology of Gene-Targeted Mouse Models for Cystic Fibrosis. Physiol. Rev. 79, Suppl.: S193-S214, 1999.  Mutations in the gene causing the fatal disease cystic fibrosis (CF) result in abnormal transport of several ions across a number of epithelial tissues. In just 3 years after this gene was cloned, the first CF mouse models were generated. The CF mouse models generated to date have provided a wealth of information on the pathophysiology of the disease in a variety of organs. Heterogeneity of disease in the mouse models is due to the variety of gene-targeting strategies used in the generation of the CF mouse models as well as the diversity of the murine genetic background. This paper reviews the pathophysiology in the tissues and organs (gastrointestinal, airway, hepatobiliary, pancreas, reproductive, and salivary tissue) involved in the disease in the various CF mouse models. Marked similarities to and differences from the human disease have been observed in the various murine models. Some of the CF mouse models accurately reflect the ion-transport abnormalities and disease phenotype seen in human CF patients, especially in gastrointestinal tissue. However, alterations in airway ion transport, which lead to the devastating lung disease in CF patients, appear to be largely absent in the CF mouse models. Reasons for these unexpected findings are discussed. This paper also reviews pharmacotherapeutic and gene therapeutic studies in the various mouse models.

This article has been cited by other articles:

				S. Beharry, C. Ackerley, M. Corey, G. Kent, Y.-M. Heng, H. Christensen, C. Luk, R. K. Yantiss, I. A. Nasser, M. Zaman, et al. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis Am J Physiol Gastrointest Liver Physiol, March 1, 2007; 292(3): G839 - G848. [Abstract] [Full Text] [PDF]

				G. Lamprecht and U. Seidler The emerging role of PDZ adapter proteins for regulation of intestinal ion transport Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G766 - G777. [Abstract] [Full Text] [PDF]

				A. L. Berger, C. O. Randak, L. S. Ostedgaard, P. H. Karp, D. W. Vermeer, and M. J. Welsh Curcumin Stimulates Cystic Fibrosis Transmembrane Conductance Regulator Cl- Channel Activity J. Biol. Chem., February 18, 2005; 280(7): 5221 - 5226. [Abstract] [Full Text] [PDF]

				A. Bouayad, H. Kajino, N. Waleh, J.-C. Fouron, G. Andelfinger, D. R. Varma, A. Skoll, A. Vazquez, F. Gobeil Jr, R. I. Clyman, et al. Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2342 - H2349. [Abstract] [Full Text] [PDF]

				K. Kim, I. Drummond, O. Ibraghimov-Beskrovnaya, K. Klinger, and M. A. Arnaout Polycystin 1 is required for the structural integrity of blood vessels PNAS, February 15, 2000; 97(4): 1731 - 1736. [Abstract] [Full Text] [PDF]